FHI vs HLNE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

FHI

61.6
AI Score
VS
FHI Wins

HLNE

53.6
AI Score

Investment Advisor Scores

FHI

62score
Recommendation
HOLD

HLNE

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FHI HLNE Winner
Forward P/E 9.9206 12.0192 FHI
PEG Ratio 1.3978 1.39 HLNE
Revenue Growth 18.3% 56.5% HLNE
Earnings Growth 19.3% 50.5% HLNE
Tradestie Score 61.6/100 53.6/100 FHI
Profit Margin 21.3% 32.1% HLNE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

FHI 1M: -11.2% · 3M: +0.5% HLNE 1M: -18.1% · 3M: +10.9%

Current Technical Phase

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.8 · Price: $57.82

HLNE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 30.4 · Price: $86.21

Fundamentals Snapshot

Metric FHI HLNE
Market Cap — —
Forward P/E 9.8 14.4
Trailing P/E 10.7 13.0
Revenue (TTM) — —
Revenue Growth 0.2% 0.6%
Gross Margin 0.7% 0.6%
Operating Margin 0.3% 0.5%
EPS 5.37 6.57
Dividend Yield 0.02% 0.03%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.